ProCE Banner Activity

Interactive Decision Support Tool: Global MCL Expert Treatment Guidance

Tool

Get recommendations from 5 global experts on MCL for your specific patient case using this interactive decision support tool.

Released: August 29, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Faculty Disclosure

Primary Author

Olivier Hermine, MD, PhD

Head Department of Clinical Hematology
Head National Center of Mastocytosis
Universite Sorbonne Paris Cite
Laboratory of cellular and molecular Mechanisms of hematological disorders and therapeutic implications
Coordinator Labex on Red Cell and Iron Metabolism
Necker Hospital and Imagine Institute
Paris, France

Olivier Hermine, MD, PhD: consultant/advisor/speaker: Bristol Myers-Squibb, Inatherys; researcher: Blueprint, Kyte, Roche; stocks/stock options: AB Science.

Marco Ladetto, MD

Associate Professor in Hematology
University of Eastern Piedmont
Director of Hematology Division
Hospital Company Saints Anthony and Biagio and Cesare Arrigo
Alessandria, Italy

Marco Ladetto, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, Amgen, AstraZeneca, Eusapharma, Gentili, Gilead/Kite, Incyte, Johnson & Johnson, Jazz, Lilly, Regeneron, Roche.

Ana Marin-Niebla, MD, PhD

Lymphoma Unit, Hematology Department
Vall d’Hebron Institute of Oncology (VHIO)
Hospital Universitario Vall d’Hebron
Barcelona, Spain

Ana Marin-Niebla, MD, PhD, has no relevant financial relationships to disclose.

Guilherme Perini, MD

Head
Center of Excellence in Lymphoma
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

Guilherme Perini, MD: consultant/advisor/speaker: AstraZeneca, Janssen, Merck, Takeda.

Max S. Topp, MD

Head of Hematology
Associate Professor of Medicine
Medical Clinic and Polyclinic
University Hospital Wurzburg
Wurzburg, Germany

Max Topp, MD: consultant/advisor/speaker: AstraZeneca, Bristol-Myers Squibb, Janssen, Kite, Roche.